课题基金 / 基金详情

Structures and clinical significance of polymorphism of human dihydrodiol dehydrogenase

Structures and clinical significance of polymorphism of human dihydrodiol dehydrogenase
人二氢二醇脱氢酶多态性的结构及临床意义
批准号:
09672240
负责人:
HARA Akira
金额:
$2.05万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

HARA Akira的其他基金

相似基金

相关文献

中文摘要
翻译
人二氢二醇脱氢酶的四种同工酶(DD1-DD4)具有83-97%的氨基酸序列同源性,基本上属于醛酮还原酶,但对内源底物和调节剂的影响不同。此外,最近报道了9个与这4种同工酶相似的cDNA,这表明它们各自的同工酶存在遗传多态性。本研究旨在阐明四种同工酶功能差异的结构决定因素、各同工酶的遗传多态性以及变异基因的临床意义。结果如下:1.重组DD3和AKR1C3与DD3相差3个氨基酸,动力学分析表明它们在功能上完全相同,3个残基不参与活性部位。底物特异性研究表明,这些酶在生理上是前列腺素D21-酮还原酶而不是羟基类固醇脱氢…。更多的罗杰斯2。同工酶的定点突变和嵌合酶的形成表明有几个氨基酸残基与底物和调节剂相互作用,并负责辅酶和激活剂的结合和/或定位。抗高脂氯贝特衍生物和抗炎2-芳基丙酸衍生物被鉴定为DD4的特异性激活剂。此外,甲状腺激素--甲状腺激素被发现是该同工酶的生理激活剂。从动力学上阐明了这些化合物的激活机理,并通过定点突变提出了同工酶激活剂结合部位的残基。我们建立了RT-PCR和RFLP方法来区分已报道的13个二氢二醇脱氢酶同工酶的cDNA。在50例人体组织标本中,仅检测到一种DD1、DD2和DD3基因的表达。结果表明,DD1、DD2和DD3的cDNA是这3个基因的主要等位基因,其他报道的cDNA来自各自同工酶基因的罕见变异或可能是测序错误。另一方面,约20%的样本显示出DD4的mRNAs杂合表达,以及一个与DD4相差2个氨基酸的变体。对137份血液样本的基因组DNA分析证实了该变异基因,其中一份样本显示该变异基因表达纯合。该变异等位基因在日语中的频率约为9%。目前,该变异基因的生理作用及其与肝病的关系尚不清楚。较少
英文摘要
Four isozymes (DD1-DD4) of human dihydrodiol dehydrogenase share 83-97% amino acid sequence identity and belong to the aldo-keto reductase fhaiily, but differ in specificity for endogenous substrates and effects by modulators. In addition, nine cDNAs similar to that for the four isozymes have recently been reported, which suggests the existence of genetic polymorphism of the respective isozymes. This study was performed to elucidate structural determinants for the functional difference among the four isozymes, genetic polymorphism of the respective isozymes, and clinical significance of the variant gene. The results obtained are summarized as follows :1. Kinetic analyses of recombinant DD3 and AKRlC3, which differs by 3 amino acids from DD3, indicated that they are functionally identical and the 3 residues are not involved in the active site. Substrate specificity study suggested that the enzymes physiologically act as prostaglandin D2 1 1-ketoreductase rather than hydroxysteroid dehyd … More rogenase.2. Site-directed mutagenesis of the isozymes and formation of chimeric enzymes suggested several amino acid residues, which interact with substrates and modulators, and are responsible for the binding and/or orientation of the coenzyme and activators.3. Anti-hyperlipidemic clofibrate derivatives and anti-inflammatory 2-arylpropionic acid derivatives were identified as activators specific for DD4. In addition, thyroxin, a thyroid hormone, was found to be the physiological activator of this isozyme. The mechanism of activation by these compounds was kinetically elucidated and residues in the activator-binding site of the isozyme were suggested by site-directed mutagenesis.4. We established the RT-PCR and RFLP methods to discriminate the 13 cDNAs reported for the dihydrodiol dehydrogenase isozymes. Only one mRNA species for DDl, DD2 and DD3, respectively, were detected in 50 human tissue samples. The result suggested that the cDNAs for DDI, DD2 and DD3 are the principal alleles of the three genes, and the other cDNAs reported are derived from rare variants of the respective isozyme genes or could be sequencing errors. On the other hand, about 20% of the samples showed heterozygous expression of mRNAs for DD4 and a variant that differs by 2 amino acids from DD4. Analysis of genomic DNA for 137 blood samples confirms this variant DD4 gene, and one of the samples showed homozygous expression of this variant gene. The frequency of this variant allele in Japanese was about 9%. The physiological effect of this variant gene and its relationship to hepatic diseases are not unclear at present. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Shiraishi Hiroaki: "Sequence of the cDNA of a human liver dihydrodiol dehydrogenase isoform (AKR1C2) and tissue distribution of its mRNA" Biochem.J.334. 399-405 (1998)
Shiraishi Hiroaki:“人肝二氢二醇脱氢酶异构体 (AKR1C2) 的 cDNA 序列及其 mRNA 的组织分布”Biochem.J.334。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsuura Kazuya: "Activation of human 3α-hydroxysteroid dehydrogenase by clofibrate derivatives" J.Pharmacol.Exp.Ther.発表予定(印刷中). (1998)
Matsuura Kazuya:“氯贝特衍生物激活人 3α-羟基类固醇脱氢酶”J.Pharmacol.Exp.Ther. 预定演示(1998 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsuura Kazuya: "Identification of a principal mRNA species for human 3α-hydroxysteroid dehydrogenase isoform (AKR1C3) that exhibits high prostaglandin D_2 11-ketoreductase activity" J.Biochem.124. 940-946 (1998)
Matsuura Kazuya:“具有高前列腺素 D_2 11-酮还原酶活性的人 3α-羟基类固醇脱氢酶亚型 (AKR1C3) 的主要 mRNA 种类的鉴定”J.Biochem.124 (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Matsuura Kazuya: "Identification of a principal mRNA species for human 3α-hydroxysteroid dehydrogenase isoform(AKRIC3)that exhibits high prostaglandin D_2 II-ketoreductase activity" J.Biochem.124・5. 940-946 (1998)
松浦和也:“具有高前列腺素 D_2 II-酮还原酶活性的人 3α-羟基类固醇脱氢酶亚型 (AKRIC3) 的主要 mRNA 种类的鉴定”J.Biochem.124·5 (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 18 条
    Automatic Generation of Graph-structural Programs by Using Swarm Intelligence of Ants
    • 批准号:
      25730149
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $0.83万
    • 财政年份:
      2013
    • 负责人:
      HARA Akira
    • 依托单位:
    DEVELOPMENT OF ANTITUMOR DRUGS TARGETING TUMOR MARKERALDO-KETO REDUCTASES
    • 批准号:
      22590102
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2010
    • 负责人:
      HARA Akira
    • 依托单位:
    The market economy and the system design of 20th century Japan
    Neuron-Like Differentiation and Selective Ablation of Undifferentiated Embryonic Stem Cells Containing Suicide Gene with Oct-4 Promoter
    • 批准号:
      19592012
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.41万
    • 财政年份:
      2007
    • 负责人:
      HARA Akira
    • 依托单位:
    海外基金